Chao Xingjuan 4

4 · Ceribell, Inc. · Filed Jul 9, 2026

AI-generated summary of this filing

Updated Jul 9, 2026

Ceribell (CBLL) CEO Chao Xingjuan Exercises Options and Sells Shares

What Happened

Chao Xingjuan, President & CEO and a director of Ceribell (CBLL), exercised options to acquire 25,000 shares at $4.70 per share (total cost $117,500) and sold a total of 39,000 shares in open-market transactions at a weighted average price of $19.90 per share (total proceeds ~$776,100). The filings show related derivative/option positions were also reported as disposed at $0 (reflecting the option exercise/settlement).

Key Details

Transaction date: July 7, 2026; Form 4 filed July 9, 2026 (timely filed within the required reporting window).
Sale price: weighted average $19.90; shares sold in multiple trades at prices ranging $19.69–$20.27 (per footnote).
Option exercise price: $4.70 per share for 25,000 shares (total $117,500).
Total proceeds from sales reported: approximately $776,100; cash paid for exercised shares: $117,500.
Shares owned after transaction: not specified in the provided excerpt of the Form 4.
Notable footnotes: transactions were effected pursuant to a Rule 10b5-1 trading plan (F1); weighted-average sale price and price range disclosed (F2); reporting person is co-trustee of a trust and disclaims beneficial ownership except to extent of pecuniary interest (F3, F4); option vesting/vesting history and that the option is fully vested/currently exercisable (F5, F6).

Context

This appears to be an exercise-and-sell sequence (options exercised and shares sold the same day), a common form of cashless or near-cashless exercise where the insider realizes the spread between the exercise price and market price. The sale activity was carried out under a pre-established 10b5-1 plan (footnote F1), which often indicates scheduled trading rather than opportunistic timing.

Form 4

Period: 2026-07-07

DirectorPresident and CEO

Transactions

Sale
Common Stock
[F1][F2]
2026-07-07$19.90/sh−14,000$278,600→ 802,317 total
Exercise/Conversion
Common Stock
[F1]
2026-07-07$4.70/sh+1,446$6,796→ 803,763 total
Sale
Common Stock
[F1][F2]
2026-07-07$19.90/sh−1,446$28,775→ 802,317 total
Exercise/Conversion
Common Stock
[F1]
2026-07-07$4.70/sh+23,554$110,704→ 825,871 total
Sale
Common Stock
[F1][F2]
2026-07-07$19.90/sh−23,554$468,725→ 802,317 total
Exercise/Conversion
Stock Option (Right to Buy)
[F1][F5]
2026-07-07−1,446→ 288,710 total
Exercise: $4.70Exp: 2033-02-16→ Common Stock (1,446 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
[F1][F6]
2026-07-07−23,554→ 77,923 total
Exercise: $4.70Exp: 2033-02-16→ Common Stock (23,554 underlying)

Holdings

Footnotes (6)

[F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.69 to $20.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.
[F3]The Reporting Person is a co-trustee of the ACP 2021 Trust, and therefore may be deemed to share beneficial ownership of these securities.
[F4]The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
[F5]The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of April 1, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
[F6]The stock option is fully vested and currently exercisable.

Signature

/s/ Louisa Daniels, Attorney-in-Fact for Xingjuan (Jane) Chao|2026-07-09

1 file